Eugenics and the Human/Animal Divide in Guardians of the Galaxy Vol. 3
By Leigha McReynolds,
Tor
| 09. 19. 2023
The 2011 X-Men franchise prequel, X-Men: First Class, briefly featured a mutant named Darwin who could adapt to any circumstances. For example, when he stuck his head in a fish tank he grew gills. Now if you’re a history of science nerd like me, you both appreciate the Darwinian reference and wish that the movie had instead named the character Lamarck, who theorized that individual animals could adapt to environments and experience physical changes during their lives—but that doesn’t have quite the same ring to it. Darwin, on the other hand, believed that species changed through heredity and over many generations.
While in this case the slippage between evolutionary theorists and their ideas is harmless, there is a long tradition of misusing Darwin’s theory of evolution through natural selection to explain and justify concepts that are not scientific but are actually actively harmful. The creation and deployment of the term “social Darwinism” is one, and the development of the pseudoscience of eugenics in the late nineteenth century is another. Eugenics took concepts rooted in Darwin’s evolutionary theory and used...
Related Articles
By Mike McIntire, The New York Times | 01.24.2026
Genetic researchers were seeking children for an ambitious, federally funded project to track brain development — a study that they told families could yield invaluable discoveries about DNA’s impact on behavior and disease.
They also promised that the children’s sensitive...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...